CTRI/2010/091/001154已完成3 期
A Controlled Labeled, Randomized Prospective, Multicentric Parallel Group, Phase-III Clinical Trial to Compare Efficacy and Safety for FDC of Eperisone150mg SR and Diclofenac 100mg SR capsule OD with Eperisone 50 mg EC Tablet T.I.D in Subjects suffering with Acute Musculoskeletal Spasm Associated With Low Backache.
Inventia Health Care Pvt. Ltd.6 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2010年7月24日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
- 试验地点
- 6
- 主要终点
- Comparison percent of reduction in pain within the last 24 hours assessed using VAS at Day 4 in both treatment groups
研究概览
简要总结
The study will be conducted after obtaining written informed consent from the subjects. The subjects will undergo medical screening during pre-study visit (Day -1). Screening will include complete clinical evaluation (medical history, physical examination, record of height, weight and vital signs).Enrolled subjects shall receive the medication for 1weeks, Day1(Visit 2). At visit3 (Day4) efficacy and ADR evaluation will be done and VAS score from subject diary would be evaluated and recorded in the case report form. At visit 4(Day 7) i.e. end of protocol therapy, efficacy, safety, tolerability and ADR monitoring will be done. Subjects are allowed to visit to investigator at any time point during the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
入选标准
- •Ages Eligible for Study: 18 Years to 70 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Patients of either sex between 18 to 70 years of age.
- •Patients with confirmed diagnosis of Acute Musculoskeletal spasm with Low Back Pain due to Spondylosis deformans, Prolapsed Intervertebral Disc (PID),- Muscle sprains with spasms.
- •Patients who are willing to take the medications as directed and willing to come for follow-ups.
- •Patients who are willing to comply with the protocol requirements.
- •Patients who are willing to give the written informed consent.
排除标准
- •Patients with other associated spasm conditions like: Traumatic pain with spasms, Cervical Spondylitis and Pain & spasm associated with fractured bone.
- •Patients who had taken any form of skeletal muscle relaxant in the previous 7 days.
- •Patients with hypersensitivity to any of the ingredients of the study drug formulations.
- •Pregnant or Lactating women or women of child bearing potential not following adequate contraceptive measures.
- •Patients unwilling or unable to comply with the study procedures.
- •Patients having a history of severe acute infection, major surgery or trauma, severe metabolic, endocrine or electrolyte disturbances and seizures in preceding 8 weeks.
- •Patients having any of the following disorders: Renal failure, Bulimia, Hypo and Hyperthyroidism Nephrotic syndrome.
- •Patients having uncontrolled diabetes mellitus, or any other metabolic or endocrine disorder.
- •Patients that have received treatment with any investigational drug in the preceding 4 weeks.
- •Patients likely to be non-compliant.
结局指标
主要结局
Comparison percent of reduction in pain within the last 24 hours assessed using VAS at Day 4 in both treatment groups
时间窗: Day 4
次要结局
- Average reduction pain within the last 24 hours assessed using VAS by Investigator and Subject at day 7 i.e. completion of protocol treatment in both treatment groups.(Day 7)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
3 期
Control- Labeled, Prospective, Randomized, Parallel group, Multicentric, Phase III Clinical Trial to Evaluate Efficacy and Safety of Eperisone HCl SR 150mg OD Capsule compared with Eperisone HCl 50mg Tablet T.I.D in patients suffering from Acute Musculoskeletal Spasm associated with Low Back Pain.CTRI/2010/091/001138Inventia Health Care Pvt Ltd200
已完成
3 期
A Control- Labeled, Prospective, Randomized, Parallel Group, Multicentric, Phase III Clinical trial to evaluate Efficacy and Safety of a FDC of Lornoxicam 16mg SR + Thiocolchicoside 16mg SR Tablet OD Compared with FDC Lornoxicam 8mg + Thiocolchicoside 8mg Capsule BID in Patients Suffering from skeletal Muscular spasm of any etiology.CTRI/2011/091/000010Alembic Ltd200
已完成
3 期
TO EVALUATE THE SAFETY AND EFFICACY FDC OF ROSUVASTATIN CALCIUM 5 mg & FENOFIBRATE 145 mg V/S ROSUVASTATIN 5mg IN PATIENTS SUFFERING WITH MIXED DYSLIPEDEMIA?.CTRI/2010/091/001437CJSC RCI Syntez200
已完成
3 期
CLINICAL TRIAL TO COMPARE EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF DOXOPHYLLINE 800 mg SR AND MONTELUKAST 10 mg WITH DOXOPHYLLINE 800mg SR IN SUBJECTS SUFFERING WITH ACUTE BRONCHOSPASMCTRI/2009/091/001041Swiss Garnier Life SciencesNo. 68A, Vembuli Amman koli St, Alandur, Chennai 600016 .Phone : 044-22329837, 22312892150
已完成
2 期
A clinical study to evaluate efficacy and safety of Seven Different Topical Formulations in Subjects Suffering from Osteoarthritis of Knee(s)Osteoarthritis of KneeCTRI/2012/05/002672Emami Limited210